Ignite Creation Date:
2025-12-24 @ 5:51 PM
Ignite Modification Date:
2026-05-15 @ 6:29 PM
Study NCT ID:
NCT05002868
Status:
COMPLETED
Last Update Posted:
2024-09-19
First Post:
2021-08-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors
Sponsor:
Rhizen Pharmaceuticals SA
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Solid Tumor | View |
| None | Extensive-stage Small-cell Lung Cancer | View |
| None | Locally Advanced Breast Cancer | View |
| None | Metastatic Breast Cancer | View |
| None | Platinum-sensitive Ovarian Cancer | View |
| None | Platinum-Sensitive Fallopian Tube Carcinoma | View |
| None | Platinum-Sensitive Peritoneal Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | PARP | View |